Ignite Creation Date:
2025-12-25 @ 2:07 AM
Ignite Modification Date:
2026-02-25 @ 8:58 PM
Study NCT ID:
NCT06812260
Status:
RECRUITING
Last Update Posted:
2025-09-17
First Post:
2025-01-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Single-arm, Open-label, Phase II Study to Evaluate Efficacy, Safety and Pharmacokinetics of HLX10 + Chemotherapy in Patients With ES-SCLC
Sponsor:
Shanghai Henlius Biotech
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-06-24
Start Date Type:
ACTUAL
Primary Completion Date:
2026-08-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-08-31
Completion Date Type:
ESTIMATED
First Submit Date:
2025-01-22
First Submit QC Date:
None
Study First Post Date:
2025-02-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-15
Last Update Post Date:
2025-09-17
Last Update Post Date Type:
ESTIMATED